Walmart to Replace AstraZeneca in Strategic Nasdaq-100 Index Update

New York, Saturday, 10 January 2026.
Replacing AstraZeneca on January 20, Walmart enters the tech-heavy Nasdaq-100, validating its digital transformation as the retailer approaches a historic $1 trillion valuation.